Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 7, 2025

Total Value ($000): $279,141 (100.0% shares, 0.0% debt)

Holdings (6)

MDXG MIMEDX GROUP INC 61.7%

Value ($000) $172,273 Shares 28,195,249 Est. Cost $7.32 Unrealized -9.2%

BVS BIOVENTUS INC 30.9%

Value ($000) $86,201 Shares 13,021,324 Est. Cost $13.37 Unrealized -47.0%

EYPT EYEPOINT PHARMACEUTICALS INC 3.9%

Value ($000) $11,008 Shares 1,169,857 Est. Cost $4.68 Unrealized +47.5%

TELA TELA BIO INC 2.9%

Value ($000) $7,975 Shares 4,110,709 Est. Cost $11.82 Unrealized -88.9%

MNOV MEDICINOVA INC 0.5%

Value ($000) $1,449 Shares 1,105,941 Est. Cost $2.95 Unrealized -52.5%

VERO VENUS CONCEPT INC 0.1%

Value ($000) $235 Shares 99,021 Est. Cost $3.59 Unrealized -26.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MDXG	MIMEDX GROUP INC	28,195,249	$172,273	61.7%	$7.32	-9.2%	COM	602496101
BVS	BIOVENTUS INC	13,021,324	$86,201	30.9%	$13.37	-47.0%	COM CL A	09075A108
EYPT	EYEPOINT PHARMACEUTICALS INC	1,169,857	$11,008	3.9%	$4.68	+47.5%	COM NEW	30233G209
TELA	TELA BIO INC	4,110,709	$7,975	2.9%	$11.82	-88.9%	COM	872381108
MNOV	MEDICINOVA INC	1,105,941	$1,449	0.5%	$2.95	-52.5%	COM NEW	58468P206
VERO	VENUS CONCEPT INC	99,021	$235	0.1%	$3.59	-26.0%	COM	92332W303